Companies: 10,795·Total market cap: $144.5T

Genenta Science S.p.A.

Genenta Science S.p.A.

GNTANASDAQHealthcare● Active

$1.80

$-0.24(-11.76%)

Market Cap$34463642

P/E Ratio—

52W High$10

52W Low$0.55

Avg Volume1.4M

Open$1.91

Beta0.90

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Genenta Science S.p.A.（GNTA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GNTA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.82Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding19.7MShares outstanding history

Next EarningsSep 2, 2026Est.Earnings history

探索 Genenta Science S.p.A. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-0.33+32.65%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$6.3M▲ +32.63% YoY

202320242025

FY 2025EPS$-0.33▲ +32.65% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$15.4MEPS: $-0.82View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.80Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Genenta Science S.p.A.

$1.80-11.76%$34.5M #2

Barinthus Biotherapeutics plc

$0.72+10.41%$29.4M #3

CEL-SCI Corporation

$1.38+0.73%$9.5M #4

INmune Bio, Inc.

$1.24-1.59%$33.0M #5

Century Therapeutics, Inc.

$2.12-0.47%$183.5M #6

Jupiter Neurosciences, Inc.

$0.23-4.58%$8.4M

股票表现

1D-11.76%

1W-8.16%

1M+187.49%

3M+109.94%

YTD+20.81%

1Y-55.00%

5Y-83.64%

关于 Genenta Science S.p.A.

CEOPierluigi Paracchi

IPO DateDec 15, 2021

Employees13

CountryIT

Websitegenenta.com

Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon,…

Biotechnology HealthcareNASDAQADRIT

关于股票概览与关键数据

Genenta Science S.p.A.（GNTA）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 15, 2021 在 NASDAQ 上市。截至最近交易日，GNTA 股价为 $1.80，市值约为 $34.5M。过去12个月累计回报 -55.00%，年初至今回报 +20.81%。

根据 1 位华尔街分析师，Genenta Science S.p.A. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Genenta Science S.p.A. 营收 —，净利润 -$6.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Genenta Science S.p.A.（GNTA）股价为 $1.80，在 NASDAQ 上市，52周区间为 $0.55 – $10.00。

GNTA 最新股价GNTA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议